Childhood central nervous system leukemia: historical perspectives, current therapy, and acute neurological sequelae

被引:43
作者
Laningham, Fred H.
Kun, Larry E.
Reddick, Wilburn E.
Ogg, Robert J.
Morris, E. Brannon
Pui, Ching-Hon
机构
[1] St Jude Childrens Hosp, Dept Radiol Sci, Div Diagnost Imaging MS 210, Memphis, TN 38105 USA
[2] St Jude Childrens Hosp, Dept Radiol Sci, Div Translat Imaging Res, Memphis, TN 38105 USA
[3] St Jude Childrens Hosp, Dept Radiol Sci, Div Radiat Oncol, Memphis, TN 38105 USA
[4] St Jude Childrens Hosp, Dept Oncol, Memphis, TN 38105 USA
[5] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA
关键词
childhood CNS leukemia; neurotoxicity; intrathecal therapy; CNS infection; secondary malignancies; methotrexate;
D O I
10.1007/s00234-007-0300-7
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction During the past three decades, improvements in the treatment of childhood leukemia have resulted in high cure rates, particularly for acute lymphoblastic leukemia (ALL). Unfortunately, successful therapy has come with a price, as significant morbidity can result from neurological affects which harm the brain and spinal cord. The expectation and hope is that chemotherapy, as a primary means of CNS therapy, will result in acceptable disease control with less CNS morbidity than has been observed with combinations of chemotherapy and radiotherapy over the past several decades. Methods and results In this review we discuss the poignant, historical aspects of CNS leukemia therapy, outline current methods of systemic and CNS leukemia therapy, and present imaging findings we have encountered in childhood leukemia patients with a variety of acute neurological conditions. A major objective of our research is to understand the neuroimaging correlates of acute and chronic effects of cancer and therapy. Specific features related to CNS leukemia and associated short-term toxicities, both disease- and therapy-related, are emphasized in this review with the specific neuroimaging findings. Specific CNS findings are similarly important when treating acute myelogenous leukemia (AML), and details of leukemic involvement and toxicities are also presented in this entity. Conclusion Despite contemporary treatment approaches which favor the use of chemotherapy (including intrathecal therapy) over radiotherapy in the treatment of CNS leukemia, children still occasionally experience morbid neurotoxicity. Standard neuroimaging is sufficient to identify a variety of neurotoxic sequelae in children, and often suggest specific etiologies. Specific neuroimaging findings frequently indicate a need to alter antileukemia therapy. It is important to appreciate that intrathecal and high doses of systemic chemotherapy are not innocuous and are associated with acute, specific, recognizable, and often serious neurological consequences.
引用
收藏
页码:873 / 888
页数:16
相关论文
共 38 条
  • [1] Bloomfield CD, 1997, CANCER-AM CANCER SOC, V80, P2191
  • [2] TREATMENT OF CHILDHOOD ACUTE NONLYMPHOBLASTIC LEUKEMIA - A REVIEW
    BOULAD, F
    KERNAN, NA
    [J]. CANCER INVESTIGATION, 1993, 11 (05) : 534 - 553
  • [3] Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia:: Significance of low leukocyte counts with blasts or traumatic lumbar puncture
    Bürger, B
    Zimmermann, M
    Mann, G
    Kühl, J
    Löning, L
    Reihm, H
    Reiter, A
    Schrappe, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (02) : 184 - 188
  • [4] Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients
    Caruso, Vanesa
    Iacoviello, Licia
    Di Castelnuovo, Augusto
    Storti, Sergio
    Mariani, Guglielmo
    de Gaetano, Giovanni
    Donati, Maria Benedetta
    [J]. BLOOD, 2006, 108 (07) : 2216 - 2222
  • [5] Chen CY, 1996, AM J NEURORADIOL, V17, P295
  • [6] Idarubicin improves blast cell clearance during induction therapy in children with AML:: results of study AML-BFM 93
    Creutzig, U
    Ritter, J
    Zimmermann, M
    Hermann, J
    Gadner, H
    Sawatzki, DB
    Niemeyer, CM
    Schwabe, D
    Selle, B
    Boos, J
    Kühl, J
    Feldges, A
    [J]. LEUKEMIA, 2001, 15 (03) : 348 - 354
  • [7] Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials
    Creutzig, U
    Zimmermann, M
    Ritter, J
    Reinhardt, D
    Hermann, J
    Henze, G
    Jürgens, H
    Kabisch, H
    Reiter, A
    Riehm, H
    Gadner, H
    Schellong, G
    [J]. LEUKEMIA, 2005, 19 (12) : 2030 - 2042
  • [8] EGUIGUREN JM, 1992, BLOOD, V79, P871
  • [9] GEORGY BA, 1994, AM J NEURORADIOL, V15, P300
  • [10] Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials
    Gibson, BES
    Wheatley, K
    Hann, IM
    Stevens, RF
    Webb, D
    Hills, RK
    De Graaf, SSN
    Harrison, CJ
    [J]. LEUKEMIA, 2005, 19 (12) : 2130 - 2138